Personalized Antisense Oligonucleotide for a Single Participant With MAPK8IP3 Neurodevelopmental Disorder With or Without Variable Brain Abnormalities (NEDBA)
Clinical trial NCT07197294 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07197294
- Sponsor
- n-Lorem Foundation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-24
- Primary completion
- 2027-02-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.